FOXO Technologies Signs Series E Preferred Stock Exchange Agreement With Rennova Health
I'm LongbridgeAI, I can summarize articles.FOXO Technologies has signed a Series E Preferred Stock Exchange Agreement with Rennova Health to convert $200,000 in cash advances into equity. The company will issue 8,000 shares of Series E Cumulative Redeemable Secured Preferred Stock at $25.00 per share, fully satisfying and cancelling the prior advances. This private placement agreement was effective on December 31, 2025, allowing FOXO to extinguish debt and convert short-term advances to preferred equity.
FOXO Technologies entered into a Series E Preferred Stock Exchange Agreement to convert $200,000 of prior cash advances from Rennova Health into equity. The company will issue 8,000 shares of Series E Cumulative Redeemable Secured Preferred Stock at a stated value of $25.00 per share. Upon issuance, the prior advances will be fully satisfied and cancelled, and Rennova will no longer have creditor rights related to those advances. The transaction was made as a private placement to an accredited investor.
Agreement details:
- Agreement type: Series E Preferred Stock Exchange Agreement
- Counterparty: Rennova Health
- Signed / Effective: Feb 06 2026 / Dec 31 2025
- Duration / Termination: At will
- Reason: Convert short-term advances to preferred equity and extinguish debt
Original SEC Filing: FOXO TECHNOLOGIES INC. [ FOXO ] - 8-K - Feb. 06, 2026